Published by Iain Gilbert on 5th September 2022
(Sharecast News) - Biotechnology company Avacta Group said on Monday that its soft tissue sarcoma treatment has been granted orphan drug designation by the US Food and Drug Administration.
URL: http://www.digitallook.com/dl/news/story/32937541/...